IL1RL1 and Myocardial fibrosis: The soluble form of ST2 acts as a decoy receptor that inhibits the cardioprotective effects of IL‐33, leading to cardiac hypertrophy, myocardial fibrosis, and ventricular dysfunction, and be used to assess the severity and prognosis of heart failure.14